XML 21 R6.htm IDEA: XBRL DOCUMENT v3.24.2
Unaudited Condensed Interim Consolidated Statements of Cash Flows - CAD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
OPERATING ACTIVITIES      
Net loss for the period $ (9,347,180) $ (6,367,772)  
Interest payment on term loan (519,206)    
Items not affecting cash:      
Deferred share units granted 281,249 173,292  
Fair value movement of deferred share units (226,602) (16,000)  
Depreciation 364,228 45,762 $ 744,783
Provision for leave and severance 123,102 86,496  
Accrued interests and accretion on loans 760,110 211,110  
Share-based payment 389,612    
Changes in non-cash working capital and non-current liability      
Prepaid expenses and other receivables 142,492 100,518  
Trade payables and accrued expenses (523,454) 17,581  
Spare parts (966,806) (212,135)  
Net cash used in operating activities (9,522,455) (5,961,148)  
INVESTING ACTIVITIES      
Acquisition of property, plant and equipment (85,096) (1,000,000)  
Net cash used in investing activities (85,096) (1,000,000)  
FINANCING ACTIVITIES      
Proceeds from issuance of units   7,765,072  
Share issue costs   (473,383)  
Vehicle loan payment (24,840) (13,044)  
Lease payment (291,280) (40,030)  
Net cash provided by/(used in) financing activities (316,120) 7,238,615  
Effect of exchange rate changes on cash and cash equivalents 44,864 (126,211)  
Change in cash and cash equivalents for the period (9,878,807) 151,256  
Cash and cash equivalents at the beginning of the period 19,245,628 5,162,991 5,162,991
Cash and cash equivalents at the end of the period 9,366,821 5,314,247 $ 19,245,628
Supplemental cash flow information      
Interest paid $ 592,440 $ 44,282